Antibody-drug conjugates: Recent advances in linker chemistry

Antibody-drug conjugates (ADCs) are gradually revolutionizing clinical cancer therapy. The antibody-drug conjugate linker molecule determines both the efficacy and the adverse effects, and so has a major influence on the fate of ADCs. An ideal linker should be stable in the circulatory system and re...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Zheng Su (Autor), Dian Xiao (Autor), Fei Xie (Autor), Lianqi Liu (Autor), Yanming Wang (Autor), Shiyong Fan (Autor), Xinbo Zhou (Autor), Song Li (Autor)
Formato: Libro
Publicado: Elsevier, 2021-12-01T00:00:00Z.
Materias:
Acceso en línea:Connect to this object online.
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

Connect to this object online.

3rd Floor Main Library

Detalle de Existencias desde 3rd Floor Main Library
Número de Clasificación: A1234.567
Copia 1 Disponible